Serum levels of soluble urokinase plasminogen activator receptor as a new inflammatory marker in adolescent obesity
dc.contributor.author | Can, Ummugulsum | |
dc.contributor.author | Buyukinan, Muammer | |
dc.contributor.author | Yerlikaya, Fatma Humeyra | |
dc.date.accessioned | 2024-02-23T14:37:48Z | |
dc.date.available | 2024-02-23T14:37:48Z | |
dc.date.issued | 2017 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Background & objectives: Obesity is known for low-grade inflammatory state with enhanced production of inflammatory mediators in children and adolescents. Soluble urokinase plasminogen activator receptor (suPAR) can be generated as a pro-inflammatory marker. This study was conducted to evaluate the role of suPAR, and its association with leptin, adiponectin, interleukin-6 (IL-6), high-sensitive C-reactive protein (hsCRP) and fibrinogen in adolescent obesity. Methods: A total of 98 participants, 55 obese individuals and 43 healthy controls, aged between 10 and 17 yr, were included in the study. Serum suPAR, IL-6, leptin and adiponectin were measured using ELISA method. Results: Serum suPAR, IL-6, fibrinogen, hsCRP and leptin levels in obese individuals were significantly higher than those of controls (P < 0.05 & P < 0.001). Serum adiponectin levels in obese individuals were significantly lower than those of controls (P < 0.01). Interpretation & conclusions: Our findings showed that suPAR, IL-6, fibrinogen, hsCRP and leptin were significantly higher in the obese individuals than those of controls. suPAR may be a good novel biomarker for systemic subclinical inflammation and immune activation linked to adolescent obesity. | en_US |
dc.description.sponsorship | Konya Education and Research Hospital, Konya, Turkey | en_US |
dc.description.sponsorship | This study was financially supported by Konya Education and Research Hospital, Konya, Turkey. | en_US |
dc.identifier.doi | 10.4103/ijmr.IJMR_1195_15 | |
dc.identifier.endpage | 333 | en_US |
dc.identifier.issn | 0971-5916 | |
dc.identifier.pmid | 28749394 | en_US |
dc.identifier.scopus | 2-s2.0-85026844617 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 327 | en_US |
dc.identifier.uri | https://doi.org/10.4103/ijmr.IJMR_1195_15 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/16244 | |
dc.identifier.volume | 145 | en_US |
dc.identifier.wos | WOS:000406918700008 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wolters Kluwer Medknow Publications | en_US |
dc.relation.ispartof | Indian Journal Of Medical Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Fibrinogen | en_US |
dc.subject | High-Sensitive C-Reactive Protein | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Obesity | en_US |
dc.subject | Soluble Urokinase Plasminogen Activator Receptor | en_US |
dc.title | Serum levels of soluble urokinase plasminogen activator receptor as a new inflammatory marker in adolescent obesity | en_US |
dc.type | Article | en_US |